A Reddit query from an aspiring or current pilot illustrates one of the more persistent friction points in the FAA medical certification process: how historical, resolved gastrointestinal illnesses are treated during an aviation medical examination. In this case, the poster describes a 2022 diagnosis of pancolitis secondary to a Campylobacter infection—an acute bacterial gastroenteritis that inflamed the entire colon before resolving fully with antibiotic treatment. With no recurrence, no chronic sequelae, and no current medications, the underlying medical picture is benign. Yet the poster's uncertainty about how to document this history to an Aviation Medical Examiner (AME), compounded by the fact that the treating physician has since retired and no continuity-of-care records exist, highlights a common administrative headache that has little to do with actual fitness to fly and everything to do with paperwork and disclosure protocol.
For working pilots, this scenario underscores why the FAA's medical certification system is often perceived as opaque and inconsistently applied. Pancolitis itself is not a specifically listed disqualifying condition under 14 CFR Part 67, but any history of gastrointestinal illness involving hospitalization, colonoscopy, or biopsy can trigger additional scrutiny on MedXPress, particularly if it was ever coded or discussed in terms suggestive of inflammatory bowel disease (IBD) such as ulcerative colitis or Crohn's disease—conditions the FAA does treat with heightened caution due to their chronic, relapsing nature and potential for in-flight incapacitation from pain, dehydration, or medication side effects. An infectious, self-limited colitis from a foodborne pathogen is categorically different from IBD, but AMEs and the FAA's Aerospace Medical Certification Division cannot always make that distinction from a vague self-report alone. This is precisely why obtaining objective documentation—old lab results confirming Campylobacter as the causative organism, discharge summaries, or even a letter from a current gastroenterologist attesting to full resolution—matters far more than the passage of time alone. Four years of asymptomatic health is reassuring clinically, but AMEs work within a system that rewards documentation over narrative.
The broader lesson for pilots and aviation medical stakeholders is that the burden of proof in FAA certification rests heavily on the applicant, not the examiner. Many pilots learn too late that failing to proactively gather old records before an exam—rather than during a deferral—can turn a routine renewal into a months-long delay while the FAA's Oklahoma City review process grinds through Special Issuance evaluations. This is a well-documented pattern across the pilot community: conditions like kidney stones, mild depression, or transient GI illnesses that pose no ongoing risk nonetheless generate disproportionate certification friction simply because the FAA's risk-averse posture treats any hospitalization or invasive diagnostic history as a flag requiring full explanation. Pilots increasingly turn to AME consultants, type-specific forums, and organizations like AOPA's Pilot Protection Services precisely because navigating this process without guidance can result in unnecessary grounding.
This case also reflects a larger trend of pilots self-educating about aeromedical risk before ever sitting in the AME's chair, a shift accelerated by online communities filling gaps left by an FAA system many view as under-resourced and slow to modernize. As the agency continues incremental efforts toward reforming BasicMed and streamlining certain Special Issuances—particularly for mental health and now increasingly for gastrointestinal and metabolic conditions—cases like this one serve as a reminder that transparency and thorough personal record-keeping remain a pilot's best defense against certification delays, regardless of how minor or resolved the underlying medical history may actually be.